Thomas Decaens (T Decaens)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Positive Airway Pressure

Cell Proliferation

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Garcia, Yan Wang, Jean Viallet, Nour El Houda Mehdi, Emilie Montaut, Thomas Decaens, Anouk Emadali, Zuzana Macek Jilkova
Liver cancer in ovo models for preclinical testing. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (17) (2024)
Lea Lerosey, Elea Ksiasek, Michal Abrahamowicz, Corinne Antoine, Sébastien Dharancy, Jérôme Dumortier, Alexandre Doussot, Vincent Di Martino, Pauline Houssel-Debry, Filomena Conti, Claire Francoz, Georges Philippe Pageaux, Ephrem Salame, Francois Faitot, Audrey Coilly, Jean Hardwigsen, Thomas Decaens, Faiza Chermak, Fabrice Muscari, Rodolphe Anty, Christophe Duvoux, Armand Abergel, Anne Minello, Thomas Mouillot, Christine Binquet, Marianne Latournerie
Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017. Liver international : official journal of the International Association for the Study of the Liver (2024)
Lea Lerosey, Elea Ksiasek, Michal Abrahamowicz, Corinne Antoine, Sébastien Dharancy, Jérôme Dumortier, Alexandre Doussot, Vincent Di Martino, Pauline Houssel-Debry, Filomena Conti, Claire Francoz, Georges Philippe Pageaux, Ephrem Salame, Francois Faitot, Audrey Coilly, Jean Hardwigsen, Thomas Decaens, Faiza Chermak, Fabrice Muscari, Rodolphe Anty, Christophe Duvoux, Armand Abergel, Anne Minello, Thomas Mouillot, Christine Binquet, Marianne Latournerie
Recipient age influences survival after liver transplant: Results of the French national cohort 2007-2017. Liver international : official journal of the International Association for the Study of the Liver 44 (6) (2024)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver 43 (3) (2023)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Lydie Carreres, Marion Mercey-Ressejac, Keerthi Kurma, Julien Ghelfi, Carole Fournier, Olivier Manches, Florent Chuffart, Sophie Rousseaux, Mélanie Minoves, Thomas Decaens, Herve Lerat, Zuzana Macek Jilkova
Chronic Intermittent Hypoxia Increases Cell Proliferation in Hepatocellular Carcinoma. Cells 11 (13) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Gaël S Roth, Olivier Hernandez, Najeh Daabek, Bleuenn Brusset, Yann Teyssier, Julien Ghelfi, Marie Noelle Hilleret, Christian Sengel, Ivan Bricault, Thomas Decaens, Charlotte Costentin
Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma. Cancers 14 (7) (2022)
Romain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna-Rita Redavid, Ievgeniia Chicherova, Marie-Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maëva Hervieu, Veronika Reiterer, Federica Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Cout, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent
Hepatic inflammation elicits production of proinflammatory netrin-1 through exclusive activation of translation. Hepatology (Baltimore, Md.) 76 (5) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: how does underlying liver disease influence therapeutic strategy and outcomes ? Liver international : official journal of the International Association for the Study of the Liver (2022)
Charlotte E Costentin, Mélanie Minoves, Sylvain Kotzki, Olivier Farges, Nathalie Goutté, Thomas Decaens, Sébastien Bailly
Alcohol-related hepatocellular carcinoma is a heterogenous condition: Lessons from a latent class analysis. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Gaël S Roth, François Villeret, Thomas Decaens, Philippe Merle, Pierre Nahon
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes? Liver international : official journal of the International Association for the Study of the Liver (2022)
Keerthi Kurma, Ayca Zeybek Kuyucu, Gaël S Roth, Nathalie Sturm, Marion Mercey-Ressejac, Giovanni Abbadessa, Yi Yu, Herve Lerat, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova
Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model. International journal of molecular sciences 23 (24) (2022)
Sonia Brun, Eloïne Bestion, Eric Raymond, Firas Bassissi, Zuzana Macek Jilkova, Soraya Mezouar, Madani Rachid, Marie Novello, Jennifer Tracz, Ahmed Hamaï, Gilles Lalmanach, Lise Vanderlynden, Raphael Legouffe, Jonathan Stauber, Thomas Schubert, Maximilian G Plach, Jérôme Courcambeck, Cyrille Drouot, Guillaume Jacquemot, Cindy Serdjebi, Gaël S Roth, Jean-Pierre Baudoin, Christelle Ansaldi, Thomas Decaens, Philippe Halfon
GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions. Autophagy (2021)
Keerthi Kurma, Olivier Manches, Florent Chuffart, Nathalie Sturm, Khaldoun Gharzeddine, Jianhui Zhang, Marion Mercey-Ressejac, Sophie Rousseaux, Arnaud Millet, Herve Lerat, Patrice N Marche, Zuzana Macek Jilkova, Thomas Decaens
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma. Cancers 13 (19) (2021)
Lydie Carreres, Zuzana Macek Jilkova, Guillaume Vial, Patrice N Marche, Thomas Decaens, Hervé Lerat
Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. Biomedicines 9 (4) (2021)
Gaël S Roth, Maxime Benhamou, Yann Teyssier, Arnaud Seigneurin, Mélodie Abousalihac, Christian Sengel, Olivier Seror, Julien Ghelfi, Nathalie Ganne-Carrié, Lorraine Blaise, Olivier Sutter, Thomas Decaens, Jean-Charles Nault
Comparison of Trans-Arterial Chemoembolization and Bland Embolization for the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis. Cancers 13 (4) (2021)
Mariam Mroweh, Gaël S Roth, Thomas Decaens, Patrice N Marche, Herve Lerat, Zuzana Macek Jilkova
Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment. International journal of molecular sciences 22 (4) (2021)
Bleuenn Brusset, Jerome Dumortier, Daniel Cherqui, Georges-Philippe Pageaux, Emmanuel Boleslawski, Ludivine Chapron, Jean-Louis Quesada, Sylvie Radenne, Didier Samuel, Francis Navarro, Sebastien Dharancy, Thomas Decaens
Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model. Cancers 13 (10) (2021)
Thomas Decaens, Carlo Barone, Eric Assenat, Martin Wermke, Angelica Fasolo, Philippe Merle, Jean-Frédéric Blanc, Véronique Grando, Angelo Iacobellis, Erica Villa, Joerg Trojan, Josef Straub, Rolf Bruns, Karin Berghoff, Juergen Scheele, Eric Raymond, Sandrine Faivre
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression. British journal of cancer 125 (2) (2021)
Zuzana Macek Jilkova, Marie Noelle Hilleret, Theophile Gerster, Nathalie Sturm, Marion Mercey-Ressejac, Jean-Pierre Zarski, Vincent Leroy, Patrice N Marche, Charlotte Costentin, Thomas Decaens
Increased Intrahepatic Expression of Immune Checkpoint Molecules in Autoimmune Liver Disease. Cells 10 (10) (2021)
Zuzana Macek Jilkova, Arnaud Seigneurin, Celine Coppard, Laurissa Ouaguia, Caroline Aspord, Patrice N Marche, Vincent Leroy, Thomas Decaens
Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals. Cancers 12 (12) (2020)
S I Malov, I V Malov, V V Dvornichenko, R I Rasulov, A G Kuvshinov, Patrice N Marche, Thomas Decaens, Zuzana Macek Jilkova, N D Yushuk
[Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.] Klinicheskaia laboratornaia diagnostika 64 (10) (2019)